Journal
BRITISH JOURNAL OF HAEMATOLOGY
Volume 171, Issue 2, Pages 210-214Publisher
WILEY
DOI: 10.1111/bjh.13563
Keywords
CSNK1A1; mutation; haploinsufficiency; 5q-syndrome; del(5q)
Categories
Funding
- Leukaemia & Lymphoma Research (UK)
Ask authors/readers for more resources
Mutations of CSNK1A1, a gene mapping to the commonly deleted region of the 5q-syndrome, have been recently described in patients with del(5q) myelodysplastic syndromes (MDS). Haploinsufficiency of Csnk1a1 in mice has been shown to result in beta-catenin activation and expansion of haematopoietic stem cells (HSC). We have screened a large cohort of 104 del(5q) MDS patients and have identified mutations of CSNK1A1 in five cases (approximately 5%). We have shown up-regulation of beta-catenin target genes in the HSC of patients with del(5q) MDS. Our data further support a central role of CSNK1A1 in the pathogenesis of MDS with del(5q).
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available